These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 8823955

  • 1. Cervical cancer control in developing countries: memorandum from a WHO meeting.
    Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
    [Abstract] [Full Text] [Related]

  • 2. Downstaging of cervical cancer.
    Ananth R.
    J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
    [Abstract] [Full Text] [Related]

  • 3. Organization of screening programs in developing countries with reference to screening for cancer of the uterine cervix in India.
    Luthra UK, Rengachari R.
    IARC Sci Publ; 1986 Feb; (76):273-88. PubMed ID: 3570411
    [Abstract] [Full Text] [Related]

  • 4. Review of screening and preventive strategies for cervical cancer in India.
    Patro BK, Nongkynrih B.
    Indian J Public Health; 2007 Feb; 51(4):216-21. PubMed ID: 18232160
    [Abstract] [Full Text] [Related]

  • 5. [Cervical cancer in developing countries. A threat to reproductive health].
    Tristen C, Bergström S.
    Lakartidningen; 1996 Sep 25; 93(39):3374-6. PubMed ID: 8926808
    [Abstract] [Full Text] [Related]

  • 6. Low cost methods for secondary prevention of cervical cancer in developing countries.
    Anorlu RI, Ola ER, Abudu OO.
    Niger Postgrad Med J; 2007 Sep 25; 14(3):242-6. PubMed ID: 17767211
    [Abstract] [Full Text] [Related]

  • 7. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
    Sankaranarayanan R, Budukh AM, Rajkumar R.
    Bull World Health Organ; 2001 Sep 25; 79(10):954-62. PubMed ID: 11693978
    [Abstract] [Full Text] [Related]

  • 8. Assessing the feasibility of single lifetime PAP smear evaluation between 41-50 years of age as strategy for cervical cancer control in developing countries from our 32 years of experience of hospital-based routine cytological screening.
    Misra JS, Gupta HP, Das V.
    Diagn Cytopathol; 2004 Dec 25; 31(6):376-9. PubMed ID: 15540174
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M, Hoque E, Kader SB.
    East Afr J Public Health; 2008 Aug 25; 5(2):111-6. PubMed ID: 19024420
    [Abstract] [Full Text] [Related]

  • 10. Early detection of cervical cancer through acetic acid application--an aided visual inspection.
    Singh V, Sehgal A, Parashari A, Sodhani P, Satyanarayana L.
    Singapore Med J; 2001 Aug 25; 42(8):351-4. PubMed ID: 11764051
    [Abstract] [Full Text] [Related]

  • 11. South Africa project provides cervical cancer screening.
    Kennedy L.
    AVSC News; 1997 Aug 25; 35(1):4-5. PubMed ID: 12293924
    [Abstract] [Full Text] [Related]

  • 12. Preventing cervical cancer.
    Jain A, Barone M.
    AVSC News; 1996 Aug 25; 34(3):2. PubMed ID: 12347474
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of cervical cancer screening programme in the Harare City Health Department, Zimbabwe.
    Moyo IM, Koni NP, Makunike B, Hipshman J, Makaure HK, Gumbo N.
    Cent Afr J Med; 1997 Aug 25; 43(8):223-5. PubMed ID: 9431759
    [Abstract] [Full Text] [Related]

  • 14. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB, Langrish SM, Stern LJ, Figueroa J, Simon CJ.
    Trop Med Int Health; 2007 Sep 25; 12(9):1018-25. PubMed ID: 17875013
    [Abstract] [Full Text] [Related]

  • 15. Cervical cancer: screening and therapeutic perspectives.
    Sankaranarayanan R, Thara S, Esmy PO, Basu P.
    Med Princ Pract; 2008 Sep 25; 17(5):351-64. PubMed ID: 18685274
    [Abstract] [Full Text] [Related]

  • 16. Reproductive cancers: women's access to screening services.
    Arrows Change; 1997 Dec 25; 3(3):1-2. PubMed ID: 12294551
    [Abstract] [Full Text] [Related]

  • 17. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L, Hakama M.
    Acta Oncol; 1997 Dec 25; 36 Suppl 9():1-60. PubMed ID: 9143316
    [Abstract] [Full Text] [Related]

  • 18. Objective screening for cervical cancer in developing nations: lessons from Nigeria.
    Roblyer D, Richards-Kortum R, Park SY, Adewole I, Follen M.
    Gynecol Oncol; 2007 Oct 25; 107(1 Suppl 1):S94-7. PubMed ID: 17825396
    [Abstract] [Full Text] [Related]

  • 19. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
    Suba EJ, Donnelly AD, Furia LM, Huynh ML, Raab SS, Viet/American Cervical Cancer Prevention Project.
    Diagn Cytopathol; 2007 Mar 25; 35(3):187-91. PubMed ID: 17304532
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology of cancer of the cervix: global and national perspective.
    Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K.
    J Indian Med Assoc; 2000 Feb 25; 98(2):49-52. PubMed ID: 11016150
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.